• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS TESTOSTERONE, TOTAL; RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS TESTOSTERONE, TOTAL; RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE Back to Search Results
Model Number 33560
Device Problem High Test Results (2457)
Patient Problem No Code Available (3191)
Event Date 04/02/2019
Event Type  Injury  
Manufacturer Narrative
The customer did not provide patient demographics such as age, date of birth, weight, ethnicity or race.The access testosterone, total reagent was not returned for evaluation.All assay and system verifications met specifications at the time of this event.No hardware errors, flags or other assay issues were reported in conjunction with this event.The access testosterone, total result obtained on the access 2 immunoassay system was discordant with testosterone testing results obtained on a competitor instrument and the patient's clinical presentation.In conclusion, the root cause of this event cannot be determined with the available information.
 
Event Description
On (b)(6) 2019 the customer reported that on (b)(6) 2019 an elevated testosterone (access testosterone, total) result had been generated on the customer's access 2 analyzer (serial number (b)(4)) for one patient sample.The initial elevated access testosterone, total result of >0.75 mg/ml was released from the laboratory.The customer reported administering medication to the patient in order to decrease the testosterone level; however, the details of what medication was administered was not provided.There was no additional change to or impact to patient care reported in association with this event.The customer reported retesting the sample on a competitor device and obtained a lower result.The customer did not provide the results or a reference range for the competitor device.Calibration was passing at the time of the event.System check was performed on (b)(6) 2019 and passed within specifications.No sample collection information such as sample type, sample tube type or size, centrifugation time or speed or any other sample processing information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS TESTOSTERONE, TOTAL
Type of Device
RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
david davis
250 s. kraemer blvd.
brea, CA 92821-8000
7149613796
MDR Report Key8535856
MDR Text Key142633277
Report Number2122870-2019-01071
Device Sequence Number1
Product Code CDZ
UDI-Device Identifier15099590231347
UDI-Public(01)15099590231347(17)190831(11)180831(10)831937
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K083867
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2019
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2019
Device Model Number33560
Device Catalogue Number33560
Device Lot Number831937
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date04/02/2019
Date Manufacturer Received04/02/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/31/2018
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-